These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6191065)

  • 1. [Biochemical study of lipids in the prostate. 2. The cholesterol and phospholipid contents, histological findings, and the weight of the excised prostate with benign hyperplasia].
    Tsugaya M
    Nihon Hinyokika Gakkai Zasshi; 1983 Feb; 74(2):172-8. PubMed ID: 6191065
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings.
    Ishigooka M; Hayami S; Hashimoto T; Suzuki Y; Katoh T; Nakada T
    Prostate; 1996 Aug; 29(2):77-82. PubMed ID: 8700803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of lipid fractions in prostate gland (author's transl)].
    Tsugaya M; Sugiura H; Otaguro K
    Nihon Hinyokika Gakkai Zasshi; 1979 Oct; 70(10):1049-54. PubMed ID: 93153
    [No Abstract]   [Full Text] [Related]  

  • 4. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
    Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
    Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cambial (stem)-zone and microcarcinoma: immunohistochemical and morphometric study approach.
    Battaglia S; Nigrisoli E; Botticelli AR; Barbolini G
    Appl Pathol; 1985; 3(4):255-61. PubMed ID: 2430599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.
    Ishigooka M; Hashimoto T; Hayami S; Suzuki Y; Sasagawa I; Nakada T
    Prostate; 1996 Jun; 28(6):385-91. PubMed ID: 8650076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid composition in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H; Krieg M
    Prostate; 1997 Jan; 30(1):41-6. PubMed ID: 9018334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia.
    Pelton K; Di Vizio D; Insabato L; Schaffner CP; Freeman MR; Solomon KR
    J Urol; 2010 Oct; 184(4):1555-9. PubMed ID: 20728125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrasonographic evaluation of the weight of prostatic adenomas. Apropos of 237 cases].
    Benassayag E; Chionis H
    Ann Urol (Paris); 1988; 22(2):151-2. PubMed ID: 2454605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the prostatic capsule in the physiopathology of benign prostatic hypertrophy].
    Sattar AA; Caufriez M; Wespes E; Noël JC; Schulman CC
    Acta Urol Belg; 1994 Sep; 62(3):43-6. PubMed ID: 7526669
    [No Abstract]   [Full Text] [Related]  

  • 12. Benign hyperplasia of the human prostate exposed to steroid hormones in organ culture.
    Harbitz TB; Falkanger B; Sander S
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():89-93. PubMed ID: 4141577
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relation between benign prostatic hyperplasia and obesity and estrogen].
    Matsuda T; Abe H; Suda K
    Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Holmium laser enucleation of the prostate--outcomes independent of prostate size?
    Humphreys MR; Miller NL; Handa SE; Terry C; Munch LC; Lingeman JE
    J Urol; 2008 Dec; 180(6):2431-5; discussion 2435. PubMed ID: 18930490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An autopsy specimen study of benign hyperplastic nodules in the peripheral zone of the prostate].
    Liu X; Tang J; Yang JC; Zhang Y; Shi HY
    Zhonghua Nan Ke Xue; 2008 Apr; 14(4):307-10. PubMed ID: 18481420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma.
    Anderson RU; Fair WR
    Invest Urol; 1976 Sep; 14(2):137-40. PubMed ID: 61187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Why does the prostate grow? Possible role of growth factors for development of benign prostatic hyperplasia].
    Tørring N; Nexø E
    Ugeskr Laeger; 1997 May; 159(19):2833-5. PubMed ID: 9190708
    [No Abstract]   [Full Text] [Related]  

  • 19. Weight, stroma to gland ratio, and mitotic activity of the human hyperplastic prostate.
    Pietilä J; Arvola I; Senius KE; Tuohimaa P
    Invest Urol; 1977 Jul; 15(1):90-2. PubMed ID: 68946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].
    Yoshida H; Haraguchi C; Ogawa Y; Kawai N; Ohyama M; Higaki Y; Saitoh T; Imamura K
    Hinyokika Kiyo; 1983 Nov; 29(11):1419-26. PubMed ID: 6203377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.